Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Teva to Invest $7.5M in Antiviral Drugmaker

By Pharmaceutical Processing | September 15, 2011

NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Thursday it will invest $7.5 million in Cocrystal Discovery Inc. to start a partnership that develops treatments for viral diseases.

Cocrystal is a Bothell, Wash.-based biotech drugmaker that studies treatments for serious and chronic antiviral diseases such as hepatitis C and influenza. Its therapies are designed to be taken orally once per day. The agreement calls for Cocrystal to develop a hepatitis C treatment for Teva. Teva will have the option to make additional investments and the right to license the drug for development and sale.

The Israeli company can make further investments for the development of two other antiviral or antibacterial drugs, and if those investments are made, Teva would take a 23-percent stake in Cocrystal.

Teva is the world’s largest maker of generic drugs. It also makes brand-name drugs including Copaxone, which is the best-selling multiple sclerosis treatment by revenue, and it is also acquiring Cephalon Inc., which makes cancer drugs, the sleep disorder drug Provigil, and pain drugs like Fentora. Shares of Teva slipped 3 cents to $38.30 in afternoon trading.

 

 

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards